By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Wealth Beat NewsWealth Beat News
  • Home
  • News
  • Finance
  • Investing
  • Banks
  • Mortgage
  • Loans
  • Credit Cards
  • Small Business
  • Dept Management
Notification Show More
Aa
Wealth Beat NewsWealth Beat News
Aa
  • News
  • Finance
  • Investing
  • Banks
  • Mortgage
  • Loans
  • Credit Cards
  • Small Business
  • Dept Management
Follow US
Wealth Beat News > News > Roku Q1 2025 Earnings: Growth Slows, But Monetization And Margins Improve
News

Roku Q1 2025 Earnings: Growth Slows, But Monetization And Margins Improve

News
Last updated: 2025/05/07 at 11:48 AM
By News
Share
1 Min Read
SHARE

Summary

  • Revenue rose 15.8% year-over-year, down from 22.0% in Q4. EBITDA growth also decelerated, landing at 36.9% compared to 62.5% the previous quarter.
  • In Q4, Total Reach Campaign usage was up 82%, but that surge hasn’t been mirrored in top-line growth – a gap that continued into Q1. That suggests ad yield and efficiency aren’t fully dialed in yet.
  • The bull case strengthens if EBITDA margins continue climbing toward (or past) 10%, ARPU keeps growing in the double digits, and Roku begins closing the gap between TRC engagement and monetization.
  • Roku is growing slightly faster, yet trades at under 2x price-to-sales, while TTD sits around 9.5x.

Roku headquarters in San Jose, California, USA

Contents
SummaryTakeaways from the Roku’s 1Q25 earnings release

Takeaways from the Roku’s 1Q25 earnings release

Yes, Roku’s revenue and EBITDA growth slowed in Q1 2025 – and it’s not just a seasonal blip. Revenue rose 15.8% year-over-year, down from 22.0% in Q4. EBITDA growth also decelerated, landing at 36.9% compared to 62.5% the previous quarter. The slowdown is

This article was written by

Ex-trading desk at tradfi bankHead of Investment Research at KRIMaster in Finance

Read the full article here

News May 7, 2025 May 7, 2025
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Fast Four Quiz: Precision Medicine in Cancer

How much do you know about precision medicine in cancer? Test your knowledge with this quick quiz.
Get Started
Excelerate Energy: Nearby Best Energy-Source Cap-Gain Prospect (NYSE:EE)

The primary focus of this article is Excelerate Energy, Inc. (NYSE:EE). Investment…

Penske Is Steady, But The Road Ahead May Be Bumpy (NYSE:PAG)

Investing Thesis On Wednesday, Penske Automotive Group (NYSE:PAG) released a superficially encouraging…

Top Financial – No, Stop It, This Is Silly (NASDAQ:TOP)

TOP Financial Moves, yes, but why? TOP Financial (NASDAQ:TOP) was quite the…

You Might Also Like

News

Sell Your CoreWeave (NASDAQ:CRWV) | Seeking Alpha

By News
News

Hormel Foods For Strong Total Return And A Rising Dividend (NYSE:HRL)

By News
News

How trivago Is A Value Trap (NASDAQ:TRVG)

By News
News

Prime Medicine: Pressing Forward With Lead Liver Targeting Indications (NASDAQ:PRME)

By News
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Contact US
More Info
  • Newsletter
  • Finance
  • Investing
  • Small Business
  • Dept Management

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions

Join Community

2025 © wealthbeatnews.com. All Rights Reserved.

Join Us!

Subscribe to our newsletter and never miss our latest news, podcasts etc.

I have read and agree to the terms & conditions
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Lost your password?